10.01.10
Nutraceutical: UltraMeal Plus 360° (medical food)
Indication: CVD risk factors
Source: American Diabetes Association 70th Scientific Sessions;June 27, 2010; Orlando, FL.
Research: A team of researchers from the University of Florida College of Medicine compared the effects of two dietary interventions on CVD (cardiovascular disease) risk factors in 47 women with metabolic syndrome. In the 12-week, two-arm, randomized, parallel group study, participants received a Mediterranean-style, low-glycemic-load diet alone or in conjunction with UltraMeal PLUS 360°.
Results: Both groups experienced improvements in the following markers of CVD risk: (1) Improvements in total cholesterol, LDL-C, apolipoprotein B (apoB) and non-high density lipoprotein cholesterol (non-HDL-C) compared to baseline; (2) Reduction in total LDL particle number. The group that additionally received UltraMeal PLUS 360° experienced: (1) Reductions in triglycerides, apoB/apoA-1, cholesterol/HDL, and small LDL particle number; (2) Greater reductions in total cholesterol, LDL-C, non-HDL-C, apoB, total LDL particle number and small LDL particle number. According to the lead researcher in the study, “All of our subjects benefited from switching to this heart-healthy diet for 12 weeks. But those who received a medical food, which contained the plant sterols, hops rho iso-alpha acids and acacia proanthocyanidins experienced additional benefits. We believe this combination of healthy eating and targeted nutrients offers an effective therapeutic option for clinicians whose patients suffer from metabolic syndrome.”